WHO ICTRP trial

Evaluating the User Experience with Omnipod 5: A whole lifespan trial.

ACTRN12625000717459 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting

Key facts

Trial ID ACTRN12625000717459
Public title Evaluating the User Experience with Omnipod 5: A whole lifespan trial.
Scientific title Evaluating the User Experience with Omnipod 5: A whole lifespan trial in People with Type 1 Diabetes (Adult [>24Y Age] Cohort Only)
Primary sponsor St Vincent's Hospital
Secondary sponsors Insulet
Registry Australian New Zealand Clinical Trials Registry (ANZCTR)
Recruitment status Not Recruiting
Study type Interventional
Phase Not Applicable
Countries Australia
Conditions Type 1 Diabetes; Type 1 Diabetes;Metabolic and Endocrine - Diabetes
Interventions Omnipod 5 is a current generation Automated Insulin Delivery (AID) enabled tubeless insulin pump. The aim is to conduct a randomised controlled study comparing the user experience with Omnipod 5 and ‘usual care’ in people living with Type 1…
Registration date Jul 7, 2025
Target size 74
Secondary IDs Nil known
Registry page anzctr.org.au

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations